We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Gemphire

News List

NeuroBo Pharmaceuticals complete Gemphire merger pharmaceutical-technology
January 14, 2020
NeuroBo Pharmaceuticals has completed its previously announced combination with Gemphire Therapeutics.The combined unit will operate as NeuroBo Pharmaceuticals with NeuroBo shareholders holding a 96.24% stake in the firm.
Gemphire to merge with NeuroBo Pharmaceuticals pharmaceutical-technology
July 26, 2019
Gemphire Therapeutics has agreed to merge with biotechnology company NeuroBo Pharmaceuticals in an all-stock transaction.
Gemphire pulls the plug on gemcabene fatty liver disease trial fiercebiotech
August 13, 2018
Things were looking up for Gemphire Therapeutics in June, when its lead drug gemcabene sailed through a midstage hypertriglyceridemia trial. Now......
Gemphire sparkles on third trial win for lead drug gemcabene fiercebiotech
July 09, 2018
Shares in Gemphire Therapeutics more than doubled after its lead drug gemcabene aced a midstage trial in patients with high triglycerides—setting up a phase 3 program.
Gemphire stock sinks as ex-Pfizer LDL drug data disappoint fiercebiotech
August 08, 2017
Gemphire shares traded down 40% following the data release.